Welcome to LookChem.com Sign In|Join Free
  • or
AKOS B018298, also known as 1-(4-fluorophenyl)ethanone, is a white, crystalline powder with a molecular formula of C8H7FO and a molecular weight of 138.14 g/mol. It is a chemical compound commonly used in the pharmaceutical industry as an intermediate in the synthesis of various pharmaceutical drugs. AKOS B018298 is considered to be a relatively stable and safe compound when handled and stored properly, and it is important to follow proper safety protocols and guidelines when working with this chemical.

23622-20-0

Post Buying Request

23622-20-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23622-20-0 Usage

Uses

Used in Pharmaceutical Industry:
AKOS B018298 is used as a building block for the production of various drug molecules. Its unique structure and properties make it a valuable component in the synthesis of pharmaceutical compounds.
AKOS B018298 is used as an intermediate in the synthesis of pharmaceutical drugs for its ability to contribute to the development of new and effective medications.
Used in Research and Development:
AKOS B018298 is also utilized in research and development processes, where it can be studied and modified to create novel drug candidates or to improve existing pharmaceutical formulations. Its versatility and stability make it a valuable tool in the ongoing pursuit of medical advancements.

Check Digit Verification of cas no

The CAS Registry Mumber 23622-20-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,6,2 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 23622-20:
(7*2)+(6*3)+(5*6)+(4*2)+(3*2)+(2*2)+(1*0)=80
80 % 10 = 0
So 23622-20-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H6ClNOS2/c11-7-3-1-2-6(4-7)5-8-9(13)12-10(14)15-8/h1-5H,(H,12,13,14)/b8-5+

23622-20-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (5E)-5-(3-Chlorobenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one

1.2 Other means of identification

Product number -
Other names (5Z)-5-(3-chlorobenzylidene)-2-thioxo-1,3-thiazolidin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23622-20-0 SDS

23622-20-0Relevant academic research and scientific papers

Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein

Li, Huan-Qiu,Yang, Jing,Ma, Shuhua,Qiao, Chunhua

experimental part, p. 4194 - 4200 (2012/08/28)

A series of novel rhodanine-based acylsulfonamide derivatives were designed, synthesized, and evaluated as small-molecule inhibitors of anti-apoptotic Bcl-2 protein. These compounds exhibit potent antiproliferative activity in three human tumor cell lines

Synthesis and characterization of (Z)-5-arylmethylidenerhodanines with photosynthesis-inhibiting properties

Opletalova, Veronika,Dolezel, Jan,Kralova, Katarina,Pesko, Matus,Kunes, Jiri,Jampilek, Josef

experimental part, p. 5207 - 5227 (2011/08/06)

A series of rhodanine derivatives was prepared. The synthetic approach, analytical and spectroscopic data of all synthesized compounds are presented. Lipophilicity of all the discussed rhodanine derivatives was analyzed using the RP-HPLC method. The compo

COMPOUNDS USEFUL AS HYPOGLYCEMIC AGENTS AND FOR TREATING ALZHEIMER'S DISEASE

-

, (2008/06/13)

Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulation

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23622-20-0